Inherited risk of women's cancers: what's changed for the practicing physician?
Frank
Thomas S
TS
Myriad Genetic Laboratories, Salt Lake City, Utah, USA. tfrank@myriad.com
Critchfield
Gregory C
GC
D048868:Adaptor Proteins, Signal Transducing; D001943:Breast Neoplasms / Q000235:genetics* / Q000601:surgery; D002352:Carrier Proteins; D004268:DNA-Binding Proteins; D016889:Endometrial Neoplasms / Q000235:genetics; D005260:Female; D019398:Genes, BRCA1 / Q000502:physiology; D024522:Genes, BRCA2 / Q000502:physiology; D005833:Genital Neoplasms, Female / Q000235:genetics*; D006801:Humans; D015273:Insurance Selection Bias; D007348:Insurance, Health; D008487:Medical History Taking; D000070957:MutL Protein Homolog 1; D051718:MutS Homolog 2 Protein; D009154:Mutation; D009363:Neoplasm Proteins / Q000235:genetics; D009687:Nuclear Proteins; D010051:Ovarian Neoplasms / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000235:genetics; D014481:United States
D048868:Adaptor Proteins, Signal Transducing; D002352:Carrier Proteins; D004268:DNA-Binding Proteins; C501486:MLH1 protein, human; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins; C497172:MSH2 protein, human; D000070957:MutL Protein Homolog 1; D051718:MutS Homolog 2 Protein